Is it Time for a Therapeutic Algorithm in Resected Pancreatic Ductal Adenocarcinoma?

Pancreas. 2020 Jan;49(1):e11. doi: 10.1097/MPA.0000000000001449.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Algorithms
  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Pancreatic Ductal*
  • Deoxycytidine / analogs & derivatives
  • Gemcitabine
  • Humans
  • Pancreatic Neoplasms*

Substances

  • Deoxycytidine
  • Gemcitabine